TGTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,645,995.97

TG Therapeutics Insider Trading History Chart

TG Therapeutics Share Price & Price History

^$35.07

▲ +0.52 (1.51%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

50-year Wall Street legend: “Sell this tech stock NOW”

From Chaikin Analytics | Ad

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

TG Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2024	Sagar Lonial	Director	Sell	5,000	$30.44	$152,200.00	100,195
3/12/2024	Laurence N. Charney	Director	Sell	22,000	$15.97	$351,340.00	215,229
1/5/2024	Laurence N. Charney	Director	Sell	17,500	$19.03	$333,025.00	237,229
1/3/2024	Sean A. Power	CFO	Sell	47,867	$16.91	$809,430.97	606,969
8/11/2023	Michael S. Weiss	CEO	Buy	100,000	$10.13	$1,013,000.00	12,073,021
6/23/2023	Sagar Lonial	Director	Sell	34,854	$23.37	$814,537.98	93,878
6/2/2023	Sean A. Power	CFO	Sell	73,647	$26.70	$1,966,374.90	654,836
1/6/2023	Yann Echelard	Director	Buy	9,000	$10.64	$95,760.00	201,848
1/4/2023	Laurence N. Charney	Director	Sell	30,000	$11.10	$333,000.00	234,729
1/4/2022	Michael S. Weiss	CEO	Sell	37,549	$19.20	$720,940.80
1/4/2022	Sean A. Power	CFO	Sell	75,312	$19.20	$1,445,990.40

New post-election stock warning from Wall Street

From Chaikin Analytics | Ad

If you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first time in history...

Not everything is as rosy as it seems on Wall Street.

SEC Filings (Institutional Ownership Changes) for TG Therapeutics (NASDAQ:TGTX)

58.58% of TG Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

TG Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2024	Teachers Retirement System of The State of Kentucky	44,450	$1.04M	0.0%	N/A	0.029%
11/18/2024	Neo Ivy Capital Management	100,780	$2.36M	0.8%	N/A	0.065%
11/16/2024	Geode Capital Management LLC	3,205,228	$74.98M	0.0%	0.0%	2.059%
11/15/2024	Barclays PLC	347,057	$8.12M	0.0%	+83.9%	0.223%
11/15/2024	Castleark Management LLC	168,810	$3.95M	0.2%	N/A	0.108%
11/15/2024	Wellington Management Group LLP	73,320	$1.72M	0.0%	+12.7%	0.047%
11/15/2024	State Street Corp	9,094,158	$212.71M	0.0%	+35.8%	5.842%
11/15/2024	Parkman Healthcare Partners LLC	126,471	$2.96M	0.4%	-29.9%	0.081%
11/15/2024	HighTower Advisors LLC	12,526	$0.29M	0.0%	+19.6%	0.008%
11/14/2024	PFM Health Sciences LP	233,410	$5.46M	0.3%	N/A	0.150%
11/14/2024	PDT Partners LLC	60,669	$1.42M	0.1%	N/A	0.039%
11/14/2024	Verition Fund Management LLC	45,699	$1.07M	0.0%	-12.6%	0.029%
11/14/2024	Captrust Financial Advisors	30,327	$0.71M	0.0%	+21.1%	0.019%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	293,927	$6.88M	0.0%	-8.7%	0.189%
11/14/2024	Public Sector Pension Investment Board	283,000	$6.62M	0.0%	N/A	0.182%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	31,147	$0.73M	0.0%	+12.0%	0.020%
11/13/2024	BNP Paribas Financial Markets	117,985	$2.76M	0.0%	-17.3%	0.076%
11/13/2024	Advantage Alpha Capital Partners LP	22,379	$0.52M	0.1%	-34.2%	0.014%
11/13/2024	FMR LLC	1,184,158	$27.70M	0.0%	-2.6%	0.761%
11/13/2024	The Manufacturers Life Insurance Company	79,191	$1.85M	0.0%	-1.8%	0.051%
11/13/2024	Harvest Fund Management Co. Ltd	4,761	$0.11M	0.0%	N/A	0.003%
11/12/2024	Penserra Capital Management LLC	98,144	$2.30M	0.0%	+293.6%	0.063%
11/12/2024	Algert Global LLC	104,252	$2.44M	0.1%	-29.2%	0.067%
11/12/2024	Citigroup Inc.	168,277	$3.94M	0.0%	+125.7%	0.109%
11/12/2024	Eagle Asset Management Inc.	168,795	$3.95M	0.0%	N/A	0.109%
11/12/2024	Charles Schwab Investment Management Inc.	1,184,609	$27.71M	0.0%	+0.7%	0.765%
11/9/2024	Intech Investment Management LLC	48,263	$1.13M	0.0%	N/A	0.031%
11/8/2024	Segall Bryant & Hamill LLC	52,390	$1.23M	0.0%	N/A	0.034%
11/8/2024	Prospera Financial Services Inc	35,713	$0.84M	0.0%	-7.1%	0.023%
11/7/2024	Quest Partners LLC	10,529	$0.25M	0.0%	N/A	0.007%
11/7/2024	Swiss National Bank	286,600	$6.70M	0.0%	-0.7%	0.185%
11/7/2024	Thrivent Financial for Lutherans	104,764	$2.45M	0.0%	N/A	0.068%
11/6/2024	Mutual of America Capital Management LLC	20,064	$0.47M	0.0%	N/A	0.013%
11/6/2024	Empowered Funds LLC	46,431	$1.09M	0.0%	+3.1%	0.030%
11/6/2024	KBC Group NV	4,675	$0.11M	0.0%	+30.5%	0.003%
11/6/2024	Oppenheimer & Co. Inc.	32,470	$0.76M	0.0%	N/A	0.021%
11/5/2024	Victory Capital Management Inc.	32,679	$0.76M	0.0%	+24.7%	0.021%
11/5/2024	GSA Capital Partners LLP	10,987	$0.26M	0.0%	-55.1%	0.007%
11/5/2024	Entropy Technologies LP	31,200	$0.73M	0.1%	N/A	0.020%
11/4/2024	Los Angeles Capital Management LLC	123,401	$2.89M	0.0%	+33.7%	0.080%
11/4/2024	State of New Jersey Common Pension Fund D	82,752	$1.94M	0.0%	-27.2%	0.053%
10/31/2024	Principal Financial Group Inc.	772,188	$18.06M	0.0%	+1,549.4%	0.500%
10/30/2024	Amalgamated Bank	39,528	$0.93M	0.0%	+712.0%	0.026%
10/25/2024	Iridian Asset Management LLC CT	47,532	$1.11M	0.2%	+20.8%	0.031%
10/25/2024	New York State Teachers Retirement System	42,927	$1M	0.0%	N/A	0.028%
10/24/2024	State of Alaska Department of Revenue	76,130	$1.78M	0.0%	N/A	0.049%
10/23/2024	Louisiana State Employees Retirement System	64,500	$1.51M	0.0%	N/A	0.042%
10/23/2024	CWC Advisors LLC.	16,150	$0.38M	0.4%	N/A	0.010%
10/23/2024	Values First Advisors Inc.	2,496	$58K	0.0%	N/A	0.002%
10/23/2024	Assenagon Asset Management S.A.	170,234	$3.98M	0.0%	-65.2%	0.110%
10/23/2024	Hennion & Walsh Asset Management Inc.	98,629	$2.31M	0.1%	-2.7%	0.064%
10/22/2024	Private Advisor Group LLC	14,407	$0.34M	0.0%	+3.9%	0.009%
10/21/2024	Everence Capital Management Inc.	16,260	$0.38M	0.0%	N/A	0.011%
10/21/2024	Wealth Effects LLC	14,500	$0.34M	0.1%	-12.1%	0.009%
10/19/2024	Allspring Global Investments Holdings LLC	17,118	$0.40M	0.0%	-6.5%	0.011%
10/18/2024	Raymond James & Associates	170,160	$3.98M	0.0%	+35.9%	0.110%
10/18/2024	Blue Trust Inc.	1,516	$35K	0.0%	+127.3%	0.001%
10/16/2024	Avaii Wealth Management LLC	28,984	$0.68M	0.3%	-4.1%	0.019%
10/16/2024	Vontobel Holding Ltd.	9,500	$0.22M	0.0%	N/A	0.006%
10/15/2024	NBC Securities Inc.	1,309	$30K	0.0%	+58.9%	0.001%
10/11/2024	Creative Planning	55,832	$1.31M	0.0%	+19.2%	0.036%
10/11/2024	ORG Wealth Partners LLC	2,252	$53K	0.0%	N/A	0.001%
10/10/2024	Valeo Financial Advisors LLC	10,223	$0.24M	0.0%	N/A	0.007%
10/8/2024	Daymark Wealth Partners LLC	40,811	$0.96M	0.0%	+73.7%	0.026%
10/5/2024	Handelsbanken Fonder AB	49,900	$1.17M	0.0%	+22.6%	0.032%
10/3/2024	SG Americas Securities LLC	23,614	$0.55M	0.0%	+181.9%	0.015%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	10,166	$0.18M	0.0%	-57.2%	0.007%
9/11/2024	Newbridge Financial Services Group Inc.	3,084	$55K	0.0%	-15.8%	0.002%
8/22/2024	Cetera Investment Advisers	53,425	$0.95M	0.0%	-15.3%	0.035%
8/19/2024	Point72 Asset Management L.P.	585,873	$10.42M	0.0%	N/A	0.379%
8/16/2024	Quarry LP	6,003	$0.11M	0.0%	+9.1%	0.004%
8/16/2024	Creative Planning	46,839	$0.83M	0.0%	+34.7%	0.030%
8/16/2024	Algert Global LLC	147,218	$2.62M	0.1%	+193.8%	0.095%
8/15/2024	Lighthouse Investment Partners LLC	111,092	$1.98M	0.1%	N/A	0.072%
8/15/2024	The Manufacturers Life Insurance Company	80,664	$1.44M	0.0%	+3.7%	0.052%
8/15/2024	Millennium Management LLC	1,457,908	$25.94M	0.0%	-57.4%	0.943%
8/15/2024	Dark Forest Capital Management LP	41,252	$0.73M	0.1%	N/A	0.027%
8/15/2024	AQR Capital Management LLC	38,025	$0.68M	0.0%	-14.3%	0.025%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	10,166	$0.18M	0.0%	-57.2%	0.007%
8/15/2024	Point72 Europe London LLP	160,769	$2.86M	0.2%	N/A	0.104%
8/14/2024	Squarepoint Ops LLC	51,711	$0.92M	0.0%	-15.6%	0.033%
8/14/2024	Marshall Wace LLP	2,051,762	$36.50M	0.0%	N/A	1.328%
8/14/2024	Magnetar Financial LLC	36,753	$0.65M	0.0%	-29.5%	0.024%
8/14/2024	Hood River Capital Management LLC	1,572,929	$27.98M	0.6%	+6.7%	1.018%
8/14/2024	ProShare Advisors LLC	18,575	$0.33M	0.0%	-25.4%	0.012%
8/14/2024	Profund Advisors LLC	62,616	$1.11M	0.0%	-27.0%	0.041%
8/13/2024	Sei Investments Co.	37,557	$0.67M	0.0%	-3.3%	0.024%
8/13/2024	Canada Pension Plan Investment Board	1,500	$27K	0.0%	-96.7%	0.001%
8/12/2024	XTX Topco Ltd	22,176	$0.40M	0.0%	N/A	0.014%
8/12/2024	E Fund Management Co. Ltd.	20,465	$0.36M	0.0%	-20.8%	0.013%
8/10/2024	Sofinnova Investments Inc.	1,861,277	$33.11M	1.7%	-6.2%	1.204%
8/9/2024	Renaissance Technologies LLC	309,371	$5.50M	0.0%	-63.2%	0.200%
8/8/2024	J.W. Cole Advisors Inc.	15,700	$0.28M	0.0%	-18.9%	0.010%
8/8/2024	State of New Jersey Common Pension Fund D	113,683	$2.02M	0.0%	N/A	0.074%
8/7/2024	Headlands Technologies LLC	6,980	$0.12M	0.0%	N/A	0.005%
8/7/2024	Ashton Thomas Private Wealth LLC	1,986	$35K	0.0%	N/A	0.001%
8/6/2024	Strategic Financial Concepts LLC	29,776	$0.53M	0.0%	N/A	0.019%
8/6/2024	Los Angeles Capital Management LLC	92,277	$1.64M	0.0%	+20.4%	0.060%
8/5/2024	Arizona State Retirement System	41,069	$0.73M	0.0%	+3.9%	0.027%
8/5/2024	Victory Capital Management Inc.	26,212	$0.47M	0.0%	+24.6%	0.017%

Data available starting January 2016

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.

Today's Range

Now: $35.07

$33.71

$35.32

50 Day Range

MA: $25.62

$21.31

$35.07

52 Week Range

Now: $35.07

$12.30

$36.50

Volume

2,577,314 shs

Average Volume

4,453,207 shs

Market Capitalization

$5.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.19

Who are the company insiders with the largest holdings of TG Therapeutics?: TG Therapeutics' top insider investors include:
Michael S Weiss (CEO)
Sean A Power (CFO)
Laurence N Charney (Director)
Yann Echelard (Director)
Sagar Lonial (Director)
Learn More about top insider investors at TG Therapeutics.
Who are the major institutional investors of TG Therapeutics?: TG Therapeutics' top institutional shareholders include:
State Street Corp — 5.84%
Geode Capital Management LLC — 2.06%
Charles Schwab Investment Management Inc. — 0.77%
FMR LLC — 0.76%
Principal Financial Group Inc. — 0.50%
Barclays PLC — 0.22%
Learn More about top institutional investors of TG Therapeutics stock.
Which institutional investors are selling TG Therapeutics stock?: In the previous quarter, TGTX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Walleye Capital LLC
Parkman Healthcare Partners LLC
Algert Global LLC
FMR LLC
State of New Jersey Common Pension Fund D
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
BNP Paribas Financial Markets
In the previous year, company insiders that have sold TG Therapeutics company stock include:
Michael S Weiss (CEO)
Sean A Power (CFO)
Laurence N Charney (Director)
Learn More investors selling TG Therapeutics stock.
Which institutional investors are buying TG Therapeutics stock?: In the last quarter, TGTX stock was bought by institutional investors including:
State Street Corp
Principal Financial Group Inc.
Public Sector Pension Investment Board
PFM Health Sciences LP
Castleark Management LLC
Eagle Asset Management Inc.
Barclays PLC
Thrivent Financial for Lutherans
Within the previous year, these company insiders have bought TG Therapeutics stock:
Michael S Weiss (CEO)
Sean A Power (CFO)
Learn More investors buying TG Therapeutics stock.